Abbott Laboratories

Trending Topics

Illnesses/Symptoms/Conditions
Medical Devices
Diagnostic Tests/Monitoring De...
Institutional Use/Professional...
Drug/Device Reviews
Hospital/Clinical Devices
Approved Drugs/Devices
Cardiovascular/Heart Health
Home Use/Self-Care
Treatment Devices

Financial Coverage

10,701 millions US$
2,162 millions US$
2,303 millions US$
26.01%
October 2020
2021-02-24
USA

Related Companies

Abbott Laboratories
Alere Inc.
AstraZeneca AB
Boulder Brands Inc. (formerly ...
Celgene Corp.
Center for Science in the Publ...
Danone SA
Fonterra Co-operative Group Lt...
GlaxoSmithKline PLC
Hindustan Unilever Ltd.

Abbott Laboratories Financial References

ABT - Volume
Abbott Laboratories (ABT)
ABT - Shares outstanding
ABT - Market Cap
ABT - EPS Diluted (TTM)
ABT - Gross Income (TTM)
ABT - EBIT (TTM)
ABT - Research & Development Expense (TTM
ABT - Revenue per Employee (TTM)
ABT - Sales (TTM)
ABT - Earnings (TTM)
ABT - Operating Income (TTM)
ABT - Net Income Applicable to Common (TT
ABT - Net Income per Employee (TTM)
ABT - EPS - Diluted
ABT - Net Debt
ABT - Sales
ABT - Operating Income
ABT - Gross Income
ABT - Earnings
ABT - Total Capital
ABT - Free Cash Flow
ABT - EBIT
ABT - Net Income per Employee
ABT - Research & Development Expense
ABT - Net Income Applicable to Common
ABT - Total Debt
ABT - Net Income Margin
ABT - Revenue per Employee
ABT - Cash Flow from Investments
ABT - EBITDA Margin
ABT - EPS Basic (TTM)
ABT - Dividends Paid (TTM)
ABT - Capital Expenditures (CAPEX)
ABT - Cash & Equivalents
ABT - Total Liabilities
ABT - Total Assets
ABT - Gross Income Margin
ABT - EPS - Basic
ABT - Cash Flow from Financing
ABT - Working Capital
ABT - EBITDA
ABT - EBITDA (TTM)
ABT - Total Current Liabilities
ABT - Total Equity
ABT - Dividends Paid
ABT - Cash Ratio
ABT - Total Current Assets
ABT - Cash Flow from Operations
ABT - Debt-to-Equity

All content is copyrighted by Industry Intelligence, and the original respective author or source. You may not copy, recirculate, redistrubte or publish the content and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.